Oberweis Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.1M Buy
839,834
+113,094
+16% +$4.19M 0.8% 40
2025
Q4
$30.6M Buy
726,740
+5,050
+0.7% +$204K 1.12% 15
2025
Q3
$24.8M Sell
721,690
-4,800
-0.7% -$138K 0.95% 25
2025
Q2
$19.6M Sell
726,490
-42,860
-6% -$1.24M 0.85% 34
2025
Q1
$22.8M Buy
769,350
+20,630
+3% +$786K 1.14% 21
2024
Q4
$29.6M Buy
748,720
+32,800
+5% +$1.24M 1.4% 8
2024
Q3
$24.4M Buy
715,920
+61,820
+9% +$1.74M 1.25% 11
2024
Q2
$14.2M Sell
654,100
-17,600
-3% -$370K 0.87% 34
2024
Q1
$14.9M Buy
671,700
+14,890
+2% +$363K 1.08% 16
2023
Q4
$18.1M Buy
656,810
+59,270
+10% +$1.43M 1.68% 7
2023
Q3
$13.3M Buy
597,540
+115,230
+24% +$2.96M 1.42% 8
2023
Q2
$12.3M Buy
482,310
+270,130
+127% +$6.55M 1.49% 8
2023
Q1
$4.73M Buy
212,180
+119,780
+130% +$2.9M 0.73% 28
2022
Q4
$2.19M Buy
+92,400
New +$2.15M 0.47% 58
2019
Q4
Sell
-22,500
Closed -$540K 225
2019
Q3
$540K Sell
22,500
-6,300
-22% -$168K 0.12% 141
2019
Q2
$821K Sell
28,800
-10,700
-27% -$267K 0.15% 86
2019
Q1
$988K Sell
39,500
-79,700
-67% -$1.52M 0.2% 79
2018
Q4
$1.5M Buy
119,200
+31,700
+36% +$375K 0.34% 48
2018
Q3
$836K Buy
+87,500
New +$965K 0.16% 115

Other funds holding VCYT

Oberweis Asset Management's VCYT Position: Q1 2026 in Review

Oberweis Asset Management increased its Veracyte (VCYT) stake by 16% in Q1 2026, buying an estimated $4.19M and bringing the position to 839,834 shares worth $27.1M. The position accounts for 0.8% of the portfolio, ranked #40.

Oberweis Asset Management first reported a position in VCYT in Q3 2018 and has held it in 19 quarters since. The position peaked at $30.6M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Oberweis Asset Management held 839,834 shares of Veracyte worth $27.1M as of Q1 2026.
  • Oberweis Asset Management bought 113,094 Veracyte shares in Q1 2026, an estimated $4.19M.
  • Veracyte made up 0.8% of Oberweis Asset Management's portfolio in Q1 2026, its #40 holding.
  • Oberweis Asset Management first reported a position in Veracyte in Q3 2018 and has held it in 19 quarters since.
  • Oberweis Asset Management's Veracyte position peaked at $30.6M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Oberweis Asset Management's 13F filing for Q1 2026, filed 15 May 2026.